search
FDA
Trends
- 1E. coli outbreak tied to raw milk cheese sickens 13 across USโE. coli outbreak linked to raw milk cheese leads to 13 illnesses and eight hospitalizations across the US: FDA
US health regulators are investigating an E. coli outbreak linked to raw milk cheese that has caused 13 illnesses and eight hospitalizations across the country, according to the FDA. The announcement has raised renewed concerns about the safety of unpasteurized dairy products, with coverage highlighting the risks of raw milk consumption and calls for consumers to check products they may have purchased.
- 2FDA links Ecuadorian black clams to hepatitis A outbreakโFDA warns black clams from Ecuador tied to hepatitis A outbreak, 30 hospitalized
The FDA has issued a warning that black clams imported from Ecuador are linked to a hepatitis A outbreak in the United States, with 30 people hospitalized so far. Consumers are being urged to avoid the shellfish as health officials investigate the source of contamination and track additional cases connected to the product.
- 3Raw milk cheese recalled over E. coli outbreakโRaw milk cheese recalled over E. coli outbreak, FDA says
US health regulators have announced a recall of raw milk cheese linked to an ongoing E. coli outbreak, according to the FDA. Outlets including DC News Now, WTNH and NewsNation are reporting the recall, which affects consumers who may have purchased the contaminated cheese. Officials typically urge anyone with the product to discard it and seek medical care if symptoms of E. coli infection develop.
- 4Thyroid Medicine Recall Classified as FDA's Highest RiskโThyroid medicine recall classified under FDA's highest risk level https:// blog.taursnd.haus/display/1a04 1b09-206a-b7ca
A thyroid medicine has been recalled and the recall has been classified under the FDA's most serious risk level, meaning the agency considers the product potentially capable of causing serious harm or death. The news is circulating among readers discussing medication safety and whether patients taking thyroid medication need to check their supply or consult a doctor.
- 5
Disc Medicine, a clinical-stage biotech company, is facing investor investigations following an FDA letter that raised concerns for shareholders. Law firms have reportedly begun looking into whether the company misled investors about its regulatory prospects. The development puts pressure on the stock and adds uncertainty to the company's drug approval timeline, drawing attention from biotech investors tracking FDA-related setbacks.
- 6Arrowhead Pharmaceuticals Stock Nears Five-Year High on Phase 3 WinโผARWR Stock On Track To Hit Over 5-Year Highs โ Retail Cheers Phase 3 Breakthrough As Arrowhead Targets Broader FDA Approval
Arrowhead Pharmaceuticals shares are on track to reach their highest level in more than five years after positive Phase 3 trial results, with retail investors celebrating the biotech's momentum. The company is reportedly aiming for a broader FDA approval than initially expected, fueling optimism about the commercial potential of its drug pipeline and driving renewed interest in the stock.